- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.03. | dna Communications appoints Niamh Mangan as executive vice president and managing director | ||
| 27.03. | Merck's Winrevair granted FDA approval to treat pulmonary arterial hypertension in adults | ||
| 27.03. | AbbVie to expand inflammatory and autoimmune disease portfolio with $212.5m Landos acquisition | ||
| 27.03. | Sobi shares positive phase 3 results for Doptelet in paediatric patients with rare blood disorder ITP | ||
| 27.03. | ICR study shows how dormant breast cancer cells can be targeted to prevent relapse | ||
| 27.03. | Researchers reveal structural interface in lung cancer protein as potential treatment target | ||
| 27.03. | The importance of patient-centric support in boosting clinical trial patient recruitment and retention | ||
| 26.03. | AstraZeneca's Ultomiris receives FDA approval to treat rare autoimmune disease NMOSD | ||
| 26.03. | Novo Nordisk to acquire cardiovascular disease specialist Cardior in deal worth over €1bn | ||
| 26.03. | Johnson & Johnson's Opsynvi granted FDA approval in pulmonary arterial hypertension | ||
| 26.03. | Pfizer/Astellas' Xtandi receives CHMP recommendation to treat recurrent prostate cancer | ||
| 26.03. | Bristol Myers Squibb shares positive phase 3 results for Opdivo combination in advanced liver cancer | ||
| 26.03. | Headwinds loom for pharma web strategy | ||
| 25.03. | AbbVie's Elahere granted full FDA approval for previously-treated ovarian cancer | ||
| 25.03. | Novo Nordisk's Awiqli receives CHMP recommendation to treat diabetes in adults | ||
| 25.03. | Sanofi and Owkin expand AI collaboration to include drug positioning in immunology | ||
| 25.03. | Novartis' Fabhalta recommended by CHMP to treat rare blood disorder PNH | ||
| 25.03. | Women in pharma | ||
| 22.03. | UK survey reveals two-thirds of vitiligo patients struggle with mental health | ||
| 22.03. | FDA approves Italfarmaco's Duvyzat as first nonsteroidal Duchenne muscular dystrophy drug | ||
| 22.03. | UCB's Bimzelx recommended by CHMP to treat hidradenitis suppurativa in adults | ||
| 22.03. | AbbVie and Parvus Therapeutics collaborate to develop treatments for inflammatory bowel disease | ||
| 22.03. | AstraZeneca's Tagrisso combination shows promising overall survival trend in phase 3 lung cancer study | ||
| 22.03. | New blood test could identify individuals at highest risk of developing heart failure | ||
| 22.03. | Vynamic promotes Gemma Pfister to head of life sciences for Europe |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
